OKUR
OnKure Therapeutics, Inc.
NASDAQ: OKUR · HEALTHCARE · BIOTECHNOLOGY
$3.44
-12.02% today
Updated 2026-05-11
Market cap
$157.95M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$2 – $5
Volume
0.3M
OnKure Therapeutics, Inc. (OKUR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-4.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+6.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+5.1%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+10.8%
2026-03-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-1.11 | -49.5% | $3.79 | $4.07 | +7.4% |
| 2026-03-13 | $-0.99 | +14.1% | $3.52 | $3.90 | +10.8% |
| 2025-11-07 | $-1.09 | +9.0% | $3.16 | $3.07 | -2.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.74 | $-1.11 | -49.5% | — | — |
| 2025-12-31 | $-1.15 | $-0.99 | +14.1% | — | — |
| 2025-09-30 | $-1.20 | $-1.09 | +9.0% | — | — |
| 2025-06-30 | $-1.25 | $-1.14 | +8.7% | — | — |
| 2025-03-31 | $-1.38 | $-1.19 | +14.0% | — | — |
| 2024-12-31 | $-0.87 | $-1.37 | -57.5% | — | — |
| 2024-09-30 | $-0.90 | $-0.86 | +4.4% | — | — |
| 2024-06-30 | — | $-1.60 | — | — | — |
| 2024-03-31 | — | $-2.52 | — | — | — |
| 2023-12-31 | — | $-7.05 | — | — | — |
| 2023-09-30 | — | $-5.68 | — | — | — |
Frequently asked questions
Has OnKure Therapeutics, Inc. beaten earnings estimates?
OnKure Therapeutics, Inc. has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -4.4% over the last 4 quarters.
How does OKUR stock react to earnings?
OKUR stock has moved an average of +5.1% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.